The groundbreaking treatment of this peptide represents a significant breakthrough in the handling of diabetes mellitus type 2. Unlike existing drugs, tirzepatide targets multiple pathways – GLP-1 and GIP – providing greater glucose control and anticipated weight loss. Experts are studying its lo